Liffers ST, Godfrey L, Frohn L, et al. Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype (PMID: 35944927). Gut. 2023.
Category: Publication
In-vitro model to mimic T cell subset change in human PDAC organoid co-culture
Knoblauch M, Ma T, Beirith I, et al. In-vitro model to mimic T cell subset change in human PDAC organoid co-culture (PMID: 37470855). J Cancer Res Clin Oncol. Epub 2023.
Conference contribution: Lean Study Host: Towards an Automated Pipeline for Multi-Center Study Hosting
Heine L, Hörst F, Nasca E, et al. Conference contribution: Lean Study Host: Towards an Automated Pipeline for Multi-Center Study Hosting. 57th Hawaii International Conference on System Sciences HICSS 2023.
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution
Fleischer JR, Schmitt AM, Haas G, et al. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution (PMID: 36691028). Mol Cancer. 2023.
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
Farin HF, Mosa MH, Ndreshkjana B, et al. Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses (PMID: 37489084). Cancer Discov. 2023.
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction
Schneider C, Hilbert J, Genevaux F, et al. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction (PMID: 38885414). Adv Sci (Weinh). 2024.
IL-2 and TCR stimulation induce expression and secretion of IL-32beta by human T cells
Sanna FC, Benesova I, Pervan P, et al. IL-2 and TCR stimulation induce expression and secretion of IL-32beta by human T cells (PMID: 39211051). Front Immunol. 2024.
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials
Jank P, Karn T, van Mackelenbergh M, et al. An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials (PMID: 38837894). Clin Cancer Res. 2024.
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies
Hasselluhn MC, Schlosser D, Versemann L, et al. An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies (PMID: 37913894). Gastroenterology. 2024.
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation
Godfrey LK, Forster J, Liffers ST, et al. Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation (PMID: 38229153). Clin Epigenetics. 2024.
